Most behavioral health investors and operators chase the same deals in the same markets. They hear “Texas” or “Florida” and assume that’s where the opportunity is. Sometimes that’s true; often, they’re entering markets where behaviorally branded assets are expensive, regulatory scrutiny is high, and competition for clean licensure is intense.bhbusiness+3
The states with the most deal flow are not always the states where M&A actually pencils out. The platforms that create durable returns are built in markets where regulation creates smart barriers to entry rather than chronic liability, and where reimbursement and payer mix support sustainable margins.
Here’s what experienced operators and investors actually look at when evaluating addiction treatment M&A across state markets.
Why State Regulation Shapes Behavioral Health M&A Returns
Addiction treatment is regulated primarily at the state level. There’s no single federal licensure framework for IOP, PHP, or residential programs, and state rules around facility licensing, Medicaid benefits, and certificate-of-need (CON) vary widely.kff+2
Key variables that drive M&A outcomes include:
Licensure complexity and timelines
Behavioral health facility licensing processes differ significantly by state; some have relatively streamlined procedures and others impose multi-layered requirements that take many months.[pmc.ncbi.nlm.nih][youtube]
These differences show up directly in how long it takes to transfer a license post-close or stand up de novo sites.
Medicaid reimbursement and expansion status
States that expanded Medicaid under the ACA and have robust behavioral health benefit packages generally see higher utilization and more stable financing for low‑income adults with behavioral health conditions.pmc.ncbi.nlm.nih+2
At the same time, research and policy tracking highlight large state‑to‑state variation in behavioral health coverage and payment levels, even among expansion states.kff+2
Certificate-of-Need (CON) requirements
Roughly two-thirds of U.S. states have some form of CON law, but the services covered vary widely.pmc.ncbi.nlm.nih+2
Some states apply CON narrowly or have carved behavioral health out; others require CON for psychiatric or chemical dependency facilities, creating both barriers to de novo entry and embedded value in existing licensed facilities.
Payer mix and commercial penetration
States differ in commercial insurance coverage rates and in how aggressively plans reimburse outpatient behavioral health, which directly affects revenue per episode.kff+1
Many states are actively increasing Medicaid rates for outpatient behavioral health providers, but timing and magnitude differ — in FY 2024, 34 states reported increasing at least one outpatient behavioral health rate, with 25 planning further increases in 2025.[beckersbehavioralhealth]
Regulatory enforcement and oversight posture
States take different approaches to enforcement of facility standards and fraud/waste/abuse efforts. CON and licensing tracking is often used to monitor facility growth and consolidation.bhbusiness+1
Stricter oversight can protect legitimate operators from bad actors but also increases the importance of clean compliance histories in M&A due diligence.
No single factor decides whether a deal is good, but ignoring any one of them is how investors end up owning a licensed program with regulatory friction, thin margins, or an unworkable growth plan.
High Deal Flow States — and What to Watch For
Deal volume in behavioral health has cooled from its 2021 peak but remains meaningful; transactions across mental health and addiction treatment are still being driven by platform building, stabilization of labor costs, and favorable reimbursement shifts in many markets. The most active states, however, come with tradeoffs.mertztaggart+2
Texas
Texas attracts behavioral health investors for predictable reasons: a large population, no state income tax, and historically business-friendly messaging. It also has a substantial behavioral health need and an evolving policy landscape.
Considerations:
Texas has a major Medicaid footprint through STAR and STAR+PLUS, but research highlights wide state‑to‑state variation in Medicaid reimbursement and benefit design for behavioral health services.sciencedirect+2
Behavioral health operators expanding into CON states have described CON requirements as “headaches” that complicate facility development; Texas does not have a broad CON regime for behavioral health, which facilitates de novo growth but also invites competition.pmc.ncbi.nlm.nih+1
Behavioral health M&A reports note that strategic buyers are more cautious, and deals in high-profile markets can take longer to close and face more scrutiny.vmghealth+2
Bottom line: Texas offers strong demand and fewer formal barriers to de novo entry, but deal competition and payer‑mix concentration risk make underwriting discipline essential.
Florida
Florida is one of the most scrutinized addiction treatment markets, driven in part by past concerns about patient brokering and sober home abuses. Enforcement initiatives and certification requirements have reshaped the landscape.[bhbusiness]
Considerations:
Florida’s regulatory responses have raised barriers to entry and increased the importance of compliant marketing and referral practices.
Behavioral health companies expanding in CON states have reported that restrictive CON laws can place such states “at the bottom of the barrel” for expansion unless reforms narrow CON requirements for psychiatric and chemical dependency facilities.nashp+2
National M&A tracking suggests that buyers are increasingly cautious in more heavily scrutinized markets and are taking longer to complete deals.scoperesearch+1
Florida can still support attractive platforms, but compliance due diligence — especially on historical marketing, billing, and referral arrangements — has to go deeper than in many other states.
California
California is a complex but potentially high‑reward behavioral health market.
Considerations:
State-level efforts to strengthen behavioral health systems through Medicaid and complementary investments have created opportunities for expanded crisis services, integrated care, and improved rates in some benefit categories.chcs+1
At the same time, licensing and regulatory structures for behavioral health entities can be detailed and multi‑layered, with state agencies revising rules to align with broader behavioral health administration reforms.[youtube]
M&A coverage highlights that larger behavioral platforms and strategic buyers are particularly active where reimbursement changes are favorable and telehealth is well integrated, which describes many California markets.mertztaggart+1
California tends to reward operators with sophisticated licensing, compliance, and payer‑strategy capabilities; for less experienced groups, the same complexity can erode returns.
Underrated M&A Markets Worth a Serious Look
While industry attention often clusters around the same high‑profile states, research and policy tracking suggest many other states are actively strengthening behavioral health systems, increasing Medicaid rates, or easing specific barriers like CON for behavioral health — creating more nuanced opportunity maps.beckersbehavioralhealth+3
Examples of attributes that can make a state “underrated” for addiction treatment M&A:
Medicaid expansion plus behavioral health benefit growth
Studies of Medicaid expansions have found improvements in coverage and access to mental health and SUD treatment for low‑income adults.pmc.ncbi.nlm.nih+1
KFF’s survey shows many states are expanding behavioral health crisis and integration services through Medicaid.[kff]
CON reform favorable to behavioral health
Some states have scaled back CON laws specifically for psychiatric or chemical dependency facilities, even while maintaining CON for other services.nashp+2
NASHP and others are tracking multiple states debating CON reform or repeal, which can open doors for new facilities or make existing ones more valuable.pmc.ncbi.nlm.nih+2
Planned Medicaid rate increases for outpatient behavioral health
In fiscal 2024, 34 states reported increasing at least one outpatient behavioral health rate, and 25 states planned further increases for 2025.[beckersbehavioralhealth]
That environment can improve margins for IOP/PHP programs that are Medicaid-heavy or that blend Medicaid with commercial coverage.
States like Ohio, Indiana, Virginia, and others that combine Medicaid expansion, active behavioral health system strengthening, and more navigable facility rules often deliver better risk‑adjusted returns than headline markets where multiples are higher and regulatory risk is more concentrated.chcs+3
The Deal Itself: What Separates Good Acquisitions from Expensive Problems
Market selection is only half the equation. Across states, several recurring themes show up in behavioral health M&A reports and sector analyses:vmghealth+2
Licensing and CON assumptions
Deals that don’t explicitly model realistic licensing, CON review, or re-designation timelines often run into costly operating delays.
CON reviews for behavioral facilities differ widely across roughly 35 CON states, and behavioral health sometimes has a slightly more favorable posture — but not always.nashp+2
Reimbursement and payer‑mix realism
Studies and policy tracking show substantial state‑to‑state variation in Medicaid reimbursement and benefit design for behavioral health services, with some states moving aggressively to raise rates and others lagging.pubmed.ncbi.nlm.nih+3
Overly optimistic assumptions about commercial contracting, parity enforcement, or Medicaid rate increases can inflate pro formas.
Compliance and audit risk
Behavioral health is a focus area for both federal and state program integrity efforts, and M&A reports note that buyers are paying closer attention to billing patterns and audit histories before closing.scoperesearch+2
State CON and licensing regimes are also being used to monitor facility consolidation and access patterns, which can influence regulatory responses to aggressive roll‑up strategies.bhbusiness+1
Labor and leadership stability
Sector reports emphasize that stabilizing labor cost inflation has been a driver of renewed M&A activity, but workforce shortages and leadership turnover continue to create execution risk.mertztaggart+1
Losing key clinical leaders or referral relationships post‑close can materially change revenue trajectories.
Operators who treat due diligence as a technical formality rather than a central value‑protection function are the ones most likely to discover billing issues, licensure gaps, or contractual surprises after capital is deployed.
Build vs. Buy: How State Rules Shape Your Entry Strategy
For multi‑state platforms and MSOs, the strategic question is often less “Which state?” and more “Which states should we acquire in, and which should we build in?”
Key strategic considerations:
CON status and scope
In states where CON applies tightly to psychiatric or substance use facilities, de novo development may be impractical, making acquisitions the primary viable entry path.pmc.ncbi.nlm.nih+2
In states that have scaled back or exempted behavioral health from CON, de novo buildouts can be more attractive.
Licensure portability and professional licensing rules
Cross‑state practice and licensure portability for clinicians vary widely; recent reviews highlight significant state variation in supervision requirements, reciprocity, and multi-state licensure compacts.[pmc.ncbi.nlm.nih]
That variation influences how quickly you can staff and scale new programs across state lines.
Medicaid and commercial rate environments
States actively increasing outpatient behavioral health rates and adding services through Medicaid give more daylight for de novo models.sciencedirect+2
Where commercial plans pay premium rates and Medicaid behavioral benefits are narrower, acquisitions with established commercial contracts may be relatively more attractive.
De novo and acquisition each have a place. The operators who do best are the ones who start with a clear state‑by‑state regulatory and reimbursement thesis, then decide where an acquisition premium is warranted and where building from scratch offers better risk‑adjusted returns.
FAQ: Addiction Treatment M&A, State Markets, and Behavioral Health Acquisitions
1. What makes a state “business‑friendly” for behavioral health M&A?
Business‑friendly behavioral health markets typically combine manageable licensing and facility rules, Medicaid expansion with solid behavioral health benefits, limited or reformed CON requirements for psychiatric/SUD facilities, and a commercial insurance market that pays sustainable rates for outpatient behavioral health. States actively increasing Medicaid behavioral health rates or simplifying behavioral facility rules are moving in that direction.[youtube]chcs+4
2. How are behavioral health deal volumes trending?
Behavioral health M&A activity surged in 2021 and then cooled, with 2024 data showing deal volumes down from peak levels but still active, especially for platform and add‑on acquisitions in mental health and addiction treatment. Sector analyses attribute ongoing transactions to stabilizing labor costs, favorable reimbursement changes in some states, and continued demand for telehealth‑enabled services.vmghealth+2
3. How do certificate-of-need (CON) laws affect addiction treatment expansion?
CON laws, present in about two‑thirds of states, limit supply for certain health care services and can make expanding behavioral health facilities more difficult, although some states have carved out or relaxed CON for psychiatric and SUD services. For M&A, CON can make existing facilities more valuable (because new competitors face barriers) but can also slow or block post‑acquisition expansion plans.nashp+2
4. Does Medicaid expansion always make a state attractive for behavioral health M&A?
Medicaid expansion is associated with improved coverage and access to mental health and SUD care among low‑income adults, but the attractiveness of a state for M&A also depends on payment rates, benefit design, and how states implement expansion. Studies show that some expansion waivers with high cost‑sharing or limited behavioral benefits can blunt access gains.kff+3
5. Are Medicaid outpatient behavioral health rates improving?
Yes, in many states. A KFF survey found that 34 states increased rates for at least one type of outpatient behavioral health provider in FY 2024 and 25 states planned to increase outpatient behavioral rates in FY 2025. These changes can improve margins in Medicaid-heavy markets, though the size and timing of increases vary significantly by state.kff+1
6. What’s the biggest M&A risk specific to behavioral health compared to other health sectors?
Beyond the standard financial and integration risks, behavioral health deals are particularly exposed to regulatory and payer‑compliance risk — including prior billing practices, documentation standards, fraud/waste/abuse investigations, and evolving facility rules like CON. Because many behavioral health services are relatively low‑ticket but high‑volume, coding and documentation issues can accumulate into large liabilities if not caught during diligence.scoperesearch+3
Building a Multi-State Behavioral Health Platform Without Guesswork
State-specific regulation, Medicaid policy, payer contracting, and licensing are not one‑time hurdles — they’re ongoing operational realities that determine whether addiction treatment M&A actually delivers returns or just creates expensive problems.chcs+4
ForwardCare is a behavioral health MSO that partners with clinicians, entrepreneurs, and investors to launch and scale IOP, PHP, and outpatient programs. They handle the operational infrastructure — licensing support, insurance credentialing, billing, compliance, and payer strategy — so partners can focus on growth and clinical quality instead of piecing together state‑by‑state rules on their own.
If you’re evaluating behavioral health M&A or planning a multi‑state expansion and want a partner who lives in this operational detail every day, it’s worth a conversation.
